NT | MT | dual-ART | HAART | |
---|---|---|---|---|
(n=58) | (n=36) | (n=31) | (n=25) | |
In each group, number of children are classified according to clinical and immunological categories (%within rows). Immunological and virological characteristics: results expressed as mean ± 2 SE (min; max). Age expressed as median (min; max). | ||||
Clinical category | ||||
A | 46 (43.0%) | 22 (20.6%) | 20 (18.7%) | 19 (17.8%) |
B | 12 (27.9%) | 14 (32.6%) | 11 (25.6%) | 6 (14.0%) |
Age | 1.4 (0.2; 11.0) | 4.3 (0.6; 15.1) | 5.4 (0.3; 15.0) | 6.1 (1.0; 13.5) |
Immunological category | ||||
>25% CD4+ | 38 (49.4%) | 13 (16.9%) | 15 (19.5%) | 11 (14.3%) |
15–25% CD4+ | 10 (34.5%) | 9 (37.9%) | 4 (17.2%) | 3 (10.3%) |
<15% CD4+ | 7 (18.9%) | 11 (24.3%) | 12 (29.7%) | 10 (27.0%) |
Lymphocyte subsets | ||||
%CD4+ | 32.8 ± 3.76 (8; 66) | 24.8 ± 5.12 (1; 62) | 26.0 ± 6.24 (1; 55) | 22.1 ± 5.38 (1; 44) |
%CD8+ | 32.2 ± 3.82 (5; 71) | 39.5 ± 5.66 (7; 69) | 39.4 ± 8.10 (7; 60) | 48.5 ± 5.70 (21; 82) |
Viral load | ||||
Log10 VL | 4.30 ± 0.28 (2.30; 6.37) | 4.69 ± 0.36 (2.30; 6.08) | 4.55 ± 0.44 (2.30; 6.41) | 4.14 ± 0.42 (2.48; 6.06) |